Alice A. Larson - Publications

Affiliations: 
University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Pain

107/188 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Goudie-DeAngelis EM, Abdelhamid RE, Nunez MG, Kissel CL, Kovács KJ, Portoghese PS, Larson AA. Modulation of Musculoskeletal Hyperalgesia by Brown Adipose Tissue Activity in Mice. Pain. PMID 27437788 DOI: 10.1097/J.Pain.0000000000000677  0.304
2015 Larson AA, Nunez MG, Kissel CL, Kovács KJ. Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia. The European Journal of Neuroscience. PMID 26332847 DOI: 10.1111/ejn.13060  0.399
2014 Abdelhamid RE, Kovács KJ, Nunez MG, Larson AA. Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 79: 21-7. PMID 24200896 DOI: 10.1016/j.phrs.2013.10.006  0.347
2013 Abdelhamid RE, Kovács KJ, Honda CN, Nunez MG, Larson AA. Resiniferatoxin (RTX) causes a uniquely protracted musculoskeletal hyperalgesia in mice by activation of TRPV1 receptors. The Journal of Pain : Official Journal of the American Pain Society. 14: 1629-41. PMID 24188863 DOI: 10.1016/J.Jpain.2013.07.021  0.361
2013 Abdelhamid RE, Kovacs KJ, Pasley JD, Nunez MG, Larson AA. Forced swim-induced musculoskeletal hyperalgesia is mediated by CRF2 receptors but not by TRPV1 receptors. Neuropharmacology. 72: 29-37. PMID 23624287 DOI: 10.1016/j.neuropharm.2013.04.016  0.323
2005 Taiwo OB, Kovács KJ, Larson AA. Chronic daily intrathecal injections of a large volume of fluid increase mast cells in the thalamus of mice. Brain Research. 1056: 76-84. PMID 16098954 DOI: 10.1016/j.brainres.2005.07.022  0.302
2004 Kehl LJ, Kovács KJ, Larson AA. Tolerance develops to the effect of lipopolysaccharides on movement-evoked hyperalgesia when administered chronically by a systemic but not an intrathecal route. Pain. 111: 104-15. PMID 15327814 DOI: 10.1016/j.pain.2004.06.014  0.301
2004 Taiwo OB, Kovács KJ, Sperry LC, Larson AA. Naloxone-induced morphine withdrawal increases the number and degranulation of mast cells in the thalamus of the mouse. Neuropharmacology. 46: 824-35. PMID 15033342 DOI: 10.1016/j.neuropharm.2003.11.022  0.33
2003 Fang M, Kovács KJ, Fisher LL, Larson AA. Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin. The Journal of Physiology. 549: 903-17. PMID 12717003 DOI: 10.1113/jphysiol.2002.036384  0.412
2003 Tien D, Ohara PT, Larson AA, Jasmin L. Vagal afferents are necessary for the establishment but not the maintenance of kainic acid-induced hyperalgesia in mice. Pain. 102: 39-49. PMID 12620595 DOI: 10.1016/s0304-3959(02)00336-6  0.428
2002 Velázquez RA, McCarson KE, Cai Y, Kovács KJ, Shi Q, Evensjö M, Larson AA. Upregulation of neurokinin-1 receptor expression in rat spinal cord by an N-terminal metabolite of substance P. The European Journal of Neuroscience. 16: 229-41. PMID 12169105 DOI: 10.1046/j.1460-9568.2002.02064.x  0.409
2001 Kovacs KJ, Cai Y, Larson AA. Neuronal nitric oxide synthase (nNOS) mRNA is down-regulated, and constitutive NOS enzymatic activity decreased, in thoracic dorsal root ganglia and spinal cord of the rat by a substance P N-terminal metabolite. The European Journal of Neuroscience. 14: 577-84. PMID 11556883 DOI: 10.1046/j.0953-816X.2001.01675.x  0.42
2000 Larson AA, Kovács KJ, Spartz AK. Intrathecal Zn2+ attenuates morphine antinociception and the development of acute tolerance. European Journal of Pharmacology. 407: 267-72. PMID 11068022 DOI: 10.1016/S0014-2999(00)00715-9  0.383
2000 Larson AA, Giovengo SL, Russell IJ, Michalek JE. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain. 87: 201-11. PMID 10924813 DOI: 10.1016/S0304-3959(00)00284-0  0.34
2000 Larson AA, Giovengo SL, Shi Q, Velázquez RA, Kovacs KJ. Zinc in the extracellular area of the central nervous system is necessary for the development of kainic acid-induced persistent hyperalgesia in mice. Pain. 86: 177-84. PMID 10779674 DOI: 10.1016/S0304-3959(00)00244-X  0.433
2000 Larson AA, Kovacs KJ, Cooper JC, Kitto KF. Transient changes in the synthesis of nitric oxide result in long-term as well as short-term changes in acetic acid-induced writhing in mice. Pain. 86: 103-11. PMID 10779667 DOI: 10.1016/S0304-3959(00)00236-0  0.357
1999 Giovengo SL, Kitto KF, Kurtz HJ, Velázquez RA, Larson AA. Parenterally administered kainic acid induces a persistent hyperalgesia in the mouse and rat. Pain. 83: 347-58. PMID 10534608 DOI: 10.1016/S0304-3959(99)00118-9  0.475
1999 Velázquez RA, Cai Y, Shi Q, Larson AA. The distribution of zinc selenite and expression of metallothionein-III mRNA in the spinal cord and dorsal root ganglia of the rat suggest a role for zinc in sensory transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2288-300. PMID 10066279 DOI: 10.1523/Jneurosci.19-06-02288.1999  0.338
1998 Kovács KJ, Larson AA. Up-regulation of [3H]DTG but not [3H](+)-pentazocine labeled sigma sites in mouse spinal cord by chronic morphine treatment. European Journal of Pharmacology. 350: 47-52. PMID 9683013 DOI: 10.1016/S0014-2999(98)00220-9  0.347
1998 Goettl VM, Larson AA. An antagonist of substance P N-terminal fragments, D-substance P(1-7), reveals that both nociceptive and antinociceptive effects are induced by substance P N-terminal activity during noxious chemical stimulation. Brain Research. 780: 80-5. PMID 9473599 DOI: 10.1016/S0006-8993(97)01146-3  0.413
1998 Budai D, Larson AA. The involvement of metabotropic glutamate receptors in sensory transmission in dorsal horn of the rat spinal cord. Neuroscience. 83: 571-80. PMID 9460763 DOI: 10.1016/S0306-4522(97)00390-4  0.424
1997 Goettl VM, Larson DL, Portoghese PS, Larson AA. Inhibition of substance P release from spinal cord tissue after pretreatment with capsaicin does not mediate the antinociceptive effect of capsaicin in adult mice. Pain. 71: 271-8. PMID 9231870 DOI: 10.1016/S0304-3959(97)03376-9  0.409
1997 Velázquez RA, Kitto KF, Larson AA. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse. The Journal of Pharmacology and Experimental Therapeutics. 281: 1231-7. PMID 9190858  0.347
1997 Kovács KJ, Larson AA. Zn2+ inhibition of [3H]MK-801 binding is different in mouse brain and spinal cord: effect of glycine and glutamate. European Journal of Pharmacology. 324: 117-23. PMID 9137921 DOI: 10.1016/S0014-2999(97)00060-5  0.419
1996 Budai D, Larson AA. Role of substance P in the modulation of C-fiber-evoked responses of spinal dorsal horn neurons. Brain Research. 710: 197-203. PMID 8963659 DOI: 10.1016/0006-8993(95)01384-9  0.354
1996 Goettl VM, Larson AA. Nitric oxide mediates long-term hyperalgesic and antinociceptive effects of the N-terminus of substance P in the formalin assay in mice. Pain. 67: 435-41. PMID 8951939 DOI: 10.1016/0304-3959(96)03155-7  0.403
1996 Kreeger JS, Larson AA. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice. The Journal of Pharmacology and Experimental Therapeutics. 279: 662-7. PMID 8930169  0.301
1996 Hornfeldt CS, Kitto KF, Larson AA. Evidence that the NH2-terminus of substance P modulates N-methyl-D-aspartate-induced activity by an action involving sigma receptors. European Journal of Pharmacology. 306: 15-22. PMID 8813610 DOI: 10.1016/0014-2999(96)00199-9  0.408
1995 Kovács KJ, Larson AA. Discrepancies in characterization of sigma sites in the mouse central nervous system. European Journal of Pharmacology. 285: 127-34. PMID 8566130 DOI: 10.1016/0014-2999(95)00383-V  0.325
1995 Kreeger JS, Yukhananov RYu, Larson AA. Altered N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine is mediated by sigma activity. Brain Research. 672: 83-8. PMID 7749756 DOI: 10.1016/0006-8993(94)01383-S  0.449
1995 Budai D, Wilcox GL, Larson AA. Effects of nitric oxide availability on responses of spinal wide dynamic range neurons to excitatory amino acids. European Journal of Pharmacology. 278: 39-47. PMID 7545123 DOI: 10.1016/0014-2999(95)00100-Y  0.409
1994 Yukhananov RYu, Larson AA. Morphine modulates excitatory amino acid-induced activity in the mouse spinal cord: short-term effects on N-methyl-D-aspartate (NMDA) and long-term effects on kainic acid. Brain Research. 646: 194-200. PMID 8069663 DOI: 10.1016/0006-8993(94)90077-9  0.444
1994 Budai D, Larson AA. GYKI 52466 inhibits AMPA/kainate and peripheral mechanical sensory activity. Neuroreport. 5: 881-4. PMID 8061287 DOI: 10.1097/00001756-199404000-00007  0.435
1994 Goettl VM, Larson AA. Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX. Brain Research. 642: 334-8. PMID 8032897 DOI: 10.1016/0006-8993(94)90939-3  0.435
1994 Yukhananov RYu, Larson AA. Involvement of NMDA receptors in naloxone-induced contractions of the isolated guinea pig ileum after preincubation with morphine. The Journal of Pharmacology and Experimental Therapeutics. 271: 1365-70. PMID 7996448  0.301
1994 Kovács KJ, Larson AA. Density of NMDA-coupled and uncoupled 1-[1-(2-[3H]thienyl) cyclohexyl]piperidine recognition sites in the brain and spinal cord: differential effects of NMDA agonists and antagonists. Journal of Neurochemistry. 63: 1757-65. PMID 7931331 DOI: 10.1046/J.1471-4159.1994.63051757.X  0.36
1994 Kreeger JS, Yukhananov RYu, Larson AA. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal. Brain Research. 663: 101-6. PMID 7850459 DOI: 10.1016/0006-8993(94)90467-7  0.433
1994 Mousseau DD, Larson AA. Substance P analogs displace sigma binding differentially in the brain and spinal cord of the adult mouse. Metabolic Brain Disease. 9: 249-55. PMID 7530803 DOI: 10.1007/BF01991198  0.373
1994 Yukhananov RYu, Larson AA. An N-terminal fragment of substance P, substance P(1-7), down-regulates neurokinin-1 binding in the mouse spinal cord. Neuroscience Letters. 178: 163-6. PMID 7529387 DOI: 10.1016/0304-3940(94)90315-8  0.374
1994 Kreeger JS, Kitto KF, Larson AA. Substance P N-terminal metabolites and nitric oxide mediate capsaicin-induced antinociception in the adult mouse. The Journal of Pharmacology and Experimental Therapeutics. 271: 1281-5. PMID 7527854  0.352
1994 Goettl VM, Xu XJ, Larson AA, Wiesenfeld-Hallin Z. Substance P N-terminus inhibits C-fiber-dependent facilitation of the rat flexor reflex. European Journal of Pharmacology. 259: 83-6. PMID 7525313 DOI: 10.1016/0014-2999(94)90162-7  0.347
1994 Goettl VM, Larson AA. Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain. Neuroscience. 60: 375-82. PMID 7521022 DOI: 10.1016/0306-4522(94)90251-8  0.426
1994 Hornfeldt CS, Sun X, Larson AA. The NH2-terminus of substance P modulates NMDA-induced activity in the mouse spinal cord. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 3364-9. PMID 7514216 DOI: 10.1523/Jneurosci.14-05-03364.1994  0.441
1994 Kreeger JS, Larson AA. Substance P (SP) N-terminal metabolites modulate withdrawal behavior in morphine-dependent mice Regulatory Peptides. 53: S213-S214. DOI: 10.1016/0167-0115(94)90316-6  0.391
1994 Goettl VG, Larson AA. Phencyclidine (PCP) receptors mediate substance P N-terminus-induced hyperalgesia while mu-type opioid receptors mediate its antinociceptive effect Regulatory Peptides. 53: S115-S116. DOI: 10.1016/0167-0115(94)90268-2  0.43
1993 Sun X, Larson AA. MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-D-aspartate activity to inhibit behavioral sensitization to kainate. Neuroscience. 54: 773-9. PMID 8101361 DOI: 10.1016/0306-4522(93)90246-C  0.429
1993 Larson AA, Sun X. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity. Neuropharmacology. 32: 909-17. PMID 7694172 DOI: 10.1016/0028-3908(93)90147-U  0.43
1993 Sun X, Larson AA. MK-801 inhibits the effects of capsaicin in the adult mouse by an action involving phencyclidine (PCP) sites not linked to NMDA activity. Neuroreport. 4: 1147-50. PMID 7693010  0.328
1993 Larson AA, Sun X. The amino-terminus of substance P mimics and MK-801 attenuates the effects of capsaicin on nociception and kainic acid-induced behavior in the mouse. Regulatory Peptides. 46: 421-3. PMID 7692555 DOI: 10.1016/0167-0115(93)90107-J  0.38
1993 Kreeger JS, Larson AA. Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice. European Journal of Pharmacology. 238: 111-5. PMID 7691618 DOI: 10.1016/0014-2999(93)90513-H  0.388
1993 Krumins SA, Kim DC, Igwe OJ, Larson AA. DAMGO binding to mouse brain membranes: influence of salts, guanine nucleotides, substance P, and substance P fragments. Peptides. 14: 309-14. PMID 7683401 DOI: 10.1016/0196-9781(93)90046-J  0.356
1993 Larson AA, Sun X. Modulation of kainic acid-induced activity in the mouse spinal cord by the amino terminus of substance P: sensitivity to opioid antagonists. The Journal of Pharmacology and Experimental Therapeutics. 265: 159-65. PMID 7682611  0.355
1993 Skilling SR, Larson AA. Capsaicin inhibits whereas rhizotomy potentiates substance P-induced release of excitatory amino acids in the rat spinal cord in vivo. Neuroscience Letters. 150: 107-11. PMID 7682305 DOI: 10.1016/0304-3940(93)90119-6  0.44
1993 Velázquez RA, Sun X, Kurtz HJ, Larson AA. Possible role of the N-terminus of substance P in kainic acid-induced toxicity in rats. Brain Research. 624: 109-14. PMID 7504568 DOI: 10.1016/0006-8993(93)90066-V  0.421
1992 Budai D, Wilcox GL, Larson AA. Enhancement of NMDA-evoked neuronal activity by glycine in the rat spinal cord in vivo. Neuroscience Letters. 135: 265-8. PMID 1625808 DOI: 10.1016/0304-3940(92)90452-D  0.416
1992 Mousseau DD, Sun X, Larson AA. Identification of a novel receptor mediating substance P-induced behavior in the mouse. European Journal of Pharmacology. 217: 197-201. PMID 1385166 DOI: 10.1016/0014-2999(92)90849-Y  0.388
1992 Budai D, Wilcox GL, Larson AA. Modulation of N-methyl-D-aspartate and (R,S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) responses of spinal nociceptive neurons by a N-terminal fragment of substance P. European Journal of Pharmacology. 216: 441-4. PMID 1385165 DOI: 10.1016/0014-2999(92)90443-8  0.431
1992 Skilling SR, Harkness DH, Larson AA. Experimental peripheral neuropathy decreases the dose of substance P required to increase excitatory amino acid release in the CSF of the rat spinal cord. Neuroscience Letters. 139: 92-6. PMID 1383886 DOI: 10.1016/0304-3940(92)90865-5  0.42
1992 Hornfeldt CS, Smullin DH, Schamber CD, Sun X, Larson AA. Antinociceptive effects of intrathecal taurine and calcium in the mouse. Life Sciences. 50: 1925-34. PMID 1375974 DOI: 10.1016/0024-3205(92)90553-2  0.366
1992 Skilling SR, Sun X, Kurtz HJ, Larson AA. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity. Brain Research. 575: 272-8. PMID 1349253 DOI: 10.1016/0006-8993(92)90090-V  0.454
1992 Larson AA, Sun X. Amino terminus of substance P potentiates kainic acid-induced activity in the mouse spinal cord. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 4905-10. PMID 1281498 DOI: 10.1523/Jneurosci.12-12-04905.1992  0.457
1991 Baker AJ, Zornow MH, Scheller MS, Yaksh TL, Skilling SR, Smullin DH, Larson AA, Kuczenski R. Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain. Journal of Neurochemistry. 57: 1370-9. PMID 1895110 DOI: 10.1111/J.1471-4159.1991.Tb08303.X  0.316
1991 Magnusson KR, Koerner JF, Larson AA, Smullin DH, Skilling SR, Beitz AJ. NMDA-, kainate- and quisqualate-stimulated release of taurine from electrophysiologically monitored rat hippocampal slices. Brain Research. 549: 1-8. PMID 1893243 DOI: 10.1016/0006-8993(91)90592-J  0.364
1991 Daló NL, Larson AA. Spinal seizures evoked by sudden cooling of amphibian isolated spinal cords: involvement of excitatory amino acids. Cryobiology. 28: 255-67. PMID 1830837 DOI: 10.1016/0011-2240(91)90031-I  0.746
1991 Sun XF, Larson AA. Behavioral sensitization to kainic acid and quisqualic acid in mice: comparison to NMDA and substance P responses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 3111-23. PMID 1719157 DOI: 10.1523/Jneurosci.11-10-03111.1991  0.461
1991 Murray CW, Cowan A, Larson AA. Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model. Pain. 44: 179-85. PMID 1711193 DOI: 10.1016/0304-3959(91)90135-K  0.442
1991 Jeftinija S, Jeftinija K, Liu F, Skilling SR, Smullin DH, Larson AA. Excitatory amino acids are released from rat primary afferent neurons in vitro. Neuroscience Letters. 125: 191-4. PMID 1679218 DOI: 10.1016/0304-3940(91)90025-O  0.359
1990 Hornfeldt CS, Larson AA. Seizures induced by fluoroacetic acid and fluorocitric acid may involve chelation of divalent cations in the spinal cord. European Journal of Pharmacology. 179: 307-13. PMID 2364992 DOI: 10.1016/0014-2999(90)90170-B  0.357
1990 Igwe OJ, Sun X, Larson AA. Correlation of substance P-induced desensitization with substance P amino terminal metabolites in the mouse spinal cord. Peptides. 11: 817-25. PMID 1700400 DOI: 10.1016/0196-9781(90)90199-F  0.419
1990 Smullin DH, Skilling SR, Larson AA. Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord. Pain. 42: 93-101. PMID 1700356 DOI: 10.1016/0304-3959(90)91095-Z  0.441
1990 Igwe OJ, Kim DC, Seybold VS, Larson AA. Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 3653-63. PMID 1700082 DOI: 10.1523/Jneurosci.10-11-03653.1990  0.369
1990 Daló NL, Larson AA. Effects of urethane and ketamine on substance P- and excitatory amino acid-induced behavior in mice. European Journal of Pharmacology. 184: 173-7. PMID 1698643 DOI: 10.1016/0014-2999(90)90679-Z  0.751
1990 Krumins SA, Kim DC, Larson AA. Substance P modulation of DAMGO binding in the brain of CXBK and Swiss-Webster mice. Peptides. 11: 281-5. PMID 1694028 DOI: 10.1016/0196-9781(90)90083-H  0.352
1990 Skilling SR, Smullin DH, Larson AA. Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 1309-18. PMID 1691775 DOI: 10.1523/Jneurosci.10-04-01309.1990  0.444
1989 Larson AA. Intrathecal GABA, glycine, taurine or beta-alanine elicits dyskinetic movements in mice. Pharmacology, Biochemistry, and Behavior. 32: 505-9. PMID 2727012 DOI: 10.1016/0091-3057(89)90189-5  0.366
1989 Hornfeldt CS, Larson AA. Selective inhibition of excitatory amino acids by divalent cations. A novel means for distinguishing N-methyl-D-aspartic acid-, kainate- and quisqualate-mediated actions in the mouse spinal cord. The Journal of Pharmacology and Experimental Therapeutics. 251: 1064-8. PMID 2574739  0.311
1989 McDonald AJ, Beitz AJ, Larson AA, Kuriyama R, Sellitto C, Madl JE. Co-localization of glutamate and tubulin in putative excitatory neurons of the hippocampus and amygdala: an immunohistochemical study using monoclonal antibodies. Neuroscience. 30: 405-21. PMID 2568603 DOI: 10.1016/0306-4522(89)90261-3  0.311
1989 Larson AA, Igwe OJ, Seybold VS. Effects of lysergic acid diethylamide (LSD) and adjuvant-induced inflammation on desensitization to and metabolism of substance P in the mouse spinal cord. Pain. 37: 365-73. PMID 2474144 DOI: 10.1016/0304-3959(89)90202-9  0.45
1989 Krumins SA, Kim DC, Seybold VS, Larson AA. Modulation of [3H]DAGO binding by substance P (SP) and SP fragments in the mouse brain and spinal cord via MU1 interactions. Neuropeptides. 13: 225-33. PMID 2473408 DOI: 10.1016/0143-4179(89)90075-9  0.381
1988 Magnusson KR, Madl JE, Clements JR, Wu JY, Larson AA, Beitz AJ. Colocalization of taurine- and cysteine sulfinic acid decarboxylase-like immunoreactivity in the cerebellum of the rat with monoclonal antibodies against taurine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 4551-64. PMID 3199192 DOI: 10.1523/Jneurosci.08-12-04551.1988  0.315
1988 Larson AA, Beitz AJ. Glycine potentiates strychnine-induced convulsions: role of NMDA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 3822-6. PMID 2903914 DOI: 10.1523/Jneurosci.08-10-03822.1988  0.427
1988 Miller KE, Clements JR, Larson AA, Beitz AJ. Organization of glutamate-like immunoreactivity in the rat superficial dorsal horn: light and electron microscopic observations. Synapse (New York, N.Y.). 2: 28-36. PMID 2901792 DOI: 10.1002/Syn.890020106  0.368
1988 Skilling SR, Smullin DH, Beitz AJ, Larson AA. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. Journal of Neurochemistry. 51: 127-32. PMID 2898001 DOI: 10.1111/J.1471-4159.1988.Tb04845.X  0.411
1988 Igwe OJ, Felice LJ, Seybold VS, Larson AA. Optimization of high-performance liquid chromatography-radioimmunoassay protocols for the analyses of substance P and some of its metabolic fragments. Journal of Chromatography. 432: 113-26. PMID 2464606 DOI: 10.1016/S0378-4347(00)80638-6  0.353
1988 Larson AA. Desensitization to intrathecal substance P in mice: possible involvement of opioids. Pain. 32: 367-74. PMID 2452400 DOI: 10.1016/0304-3959(88)90049-8  0.399
1987 Clements JR, Madl JE, Johnson RL, Larson AA, Beitz AJ. Localization of glutamate, glutaminase, aspartate and aspartate aminotransferase in the rat midbrain periaqueductal gray. Experimental Brain Research. 67: 594-602. PMID 2888681 DOI: 10.1007/BF00247290  0.359
1986 Larson AA, Dalo NL. Quantification of tryptamine in brain using high-performance liquid chromatography. Journal of Chromatography. 375: 37-47. PMID 3958108 DOI: 10.1016/S0378-4347(00)83689-0  0.699
1986 Larson AA, Anderson EG. Action of hallucinogens on raphe-evoked dorsal root potentials (DRPs) in the cat. Pharmacology, Biochemistry, and Behavior. 24: 347-50. PMID 3952125 DOI: 10.1016/0091-3057(86)90364-3  0.37
1986 Larson AA, Brown DR, el-Atrash S, Walser MM. Pain threshold changes in adjuvant-induced inflammation: a possible model of chronic pain in the mouse. Pharmacology, Biochemistry, and Behavior. 24: 49-53. PMID 3945666 DOI: 10.1016/0091-3057(86)90043-2  0.35
1986 McCormack JK, Beitz AJ, Larson AA. Autoradiographic localization of tryptamine binding sites in the rat and dog central nervous system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 94-101. PMID 3944625 DOI: 10.1523/Jneurosci.06-01-00094.1986  0.319
1986 Magnusson KR, Larson AA, Madl JE, Altschuler RA, Beitz AJ. Co-localization of fixative-modified glutamate and glutaminase in neurons of the spinal trigeminal nucleus of the rat: an immunohistochemical and immunoradiochemical analysis. The Journal of Comparative Neurology. 247: 477-90. PMID 2873153 DOI: 10.1002/Cne.902470407  0.337
1986 Monaghan PL, Beitz AJ, Larson AA, Altschuler RA, Madl JE, Mullett MA. Immunocytochemical localization of glutamate-, glutaminase- and aspartate aminotransferase-like immunoreactivity in the rat deep cerebellar nuclei. Brain Research. 363: 364-70. PMID 2867817 DOI: 10.1016/0006-8993(86)91024-3  0.343
1986 Beitz AJ, Larson AA, Monaghan P, Altschuler RA, Mullett MM, Madl JE. Immunohistochemical localization of glutamate, glutaminase and aspartate aminotransferase in neurons of the pontine nuclei of the rat. Neuroscience. 17: 741-53. PMID 2422596 DOI: 10.1016/0306-4522(86)90042-4  0.345
1986 Jeftinija S, Raspantini C, Randić M, Yaksh TL, Go VL, Larson AA. Altered responsiveness to substance P and 5-hydroxytryptamine in cat dorsal horn neurons after 5-HT depletion with p-chlorophenylalanine. Brain Research. 368: 107-15. PMID 2420413 DOI: 10.1016/0006-8993(86)91047-4  0.309
1986 Madl JE, Larson AA, Beitz AJ. Monoclonal antibody specific for carbodiimide-fixed glutamate: immunocytochemical localization in the rat CNS. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 34: 317-26. PMID 2419390 DOI: 10.1177/34.3.2419390  0.322
1985 Beitz AJ, Larson AA. Inhibition of intrathecally administered picrotoxin- and bicuculline-induced convulsions in mice by pipecolic acid or GABA. European Journal of Pharmacology. 114: 181-7. PMID 2995078 DOI: 10.1016/0014-2999(85)90626-0  0.37
1984 Larson AA. Acute and chronic effects of LSD and 5-MeODMT on raphe-evoked dorsal root potentials in the cat. Life Sciences. 34: 1193-201. PMID 6708724 DOI: 10.1016/0024-3205(84)90092-4  0.371
1984 Larson AA. Interactions between ketamine and phencyclidine and dorsal root potentials (DRPs), evoked from the raphe nuclei. Neuropharmacology. 23: 785-91. PMID 6089025 DOI: 10.1016/0028-3908(84)90112-6  0.364
1983 Larson AA. Hyperalgesia produced by the intrathecal administration of tryptamine to rats. Brain Research. 265: 109-17. PMID 6687825 DOI: 10.1016/0006-8993(83)91339-2  0.403
1982 Larson AA. Nociception is enhanced by the intrathecal injection of 5-methoxy-N,N-dimethyltryptamine in the rat. Neuroscience Letters. 33: 323-8. PMID 7162694 DOI: 10.1016/0304-3940(82)90393-7  0.392
1982 Larson AA. Nociception in mice after chronic stress and chronic narcotic antagonists during maturation. Brain Research. 243: 323-8. PMID 7104743 DOI: 10.1016/0006-8993(82)90256-6  0.34
1982 Larson AA, Kondzielski MH. Serotonin-induced gnawing in rats: comparison with tail pinch-induced gnawing. Pharmacology, Biochemistry, and Behavior. 16: 407-9. PMID 6896237 DOI: 10.1016/0091-3057(82)90443-9  0.385
1980 Larson AA, Vaught JL, Takemori AE. The potentiation of spinal analgesia by leucine enkephalin. European Journal of Pharmacology. 61: 381-3. PMID 6892802 DOI: 10.1016/0014-2999(80)90077-1  0.568
1980 Larson AA, Armstrong MJ. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine. European Journal of Pharmacology. 68: 25-31. PMID 6161013 DOI: 10.1016/0014-2999(80)90056-4  0.402
1978 Larson AA, Takemori AE. Effect of morphine on the fate of newly transported tryptophan and 5-hydroxytryptophan in brain of rats. The Journal of Pharmacology and Experimental Therapeutics. 205: 265-73. PMID 305957  0.461
1977 Larson AA, Takemori AE. Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance. Life Sciences. 21: 1807-11. PMID 604708 DOI: 10.1016/0024-3205(77)90162-X  0.544
1977 Larson AA, Takemori AE. Effect of narcotics on the uptake of serotonin precursors by the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 200: 216-23. PMID 299890  0.481
Low-probability matches (unlikely to be authored by this person)
2005 Taiwo OB, Kovács KJ, Sun Y, Larson AA. Unilateral spinal nerve ligation leads to an asymmetrical distribution of mast cells in the thalamus of female but not male mice. Pain. 114: 131-40. PMID 15733638 DOI: 10.1016/j.pain.2004.12.002  0.297
2008 Kovács KJ, Papic JC, Larson AA. Movement-evoked hyperalgesia induced by lipopolysaccharides is not suppressed by glucocorticoids. Pain. 136: 75-84. PMID 17686584 DOI: 10.1016/j.pain.2007.06.017  0.295
1987 Madl JE, Beitz AJ, Johnson RL, Larson AA. Monoclonal antibodies specific for fixative-modified aspartate: immunocytochemical localization in the rat CNS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 2639-50. PMID 3305797 DOI: 10.1523/Jneurosci.07-09-02639.1987  0.293
1994 Larson AA, Sun X. Role of the NH2-terminus of substance P in the inhibition by capsaicin of behavioral sensitization to kainic acid-induced activity in the adult mouse. The Journal of Pharmacology and Experimental Therapeutics. 268: 366-71. PMID 7507995  0.291
1988 Madl JE, Clements JR, Beitz AJ, Wenthold RJ, Larson AA. Immunocytochemical localization of glutamate dehydrogenase in mitochondria of the cerebellum: an ultrastructural study using a monoclonal antibody. Brain Research. 452: 396-402. PMID 3401748 DOI: 10.1016/0006-8993(88)90047-9  0.29
1994 Hornfeldt CS, Larson AA. Adenosine receptors are not involved in theophylline-induced seizures. Journal of Toxicology. Clinical Toxicology. 32: 257-65. PMID 8007033 DOI: 10.3109/15563659409017958  0.287
1981 Larson AA, Chinn C, Proudfit HK, Anderson EG. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei. The Journal of Pharmacology and Experimental Therapeutics. 217: 99-104. PMID 6110778  0.282
2001 Laughlin TM, Larson AA, Wilcox GL. Mechanisms of induction of persistent nociception by dynorphin. The Journal of Pharmacology and Experimental Therapeutics. 299: 6-11. PMID 11561057  0.282
1999 Larson AA, Kitto KF. Chelation of zinc in the extracellular area of the spinal cord, using ethylenediaminetetraacetic acid disodium-calcium salt or dipicolinic acid, inhibits the antinociceptive effect of capsaicin in adult mice. The Journal of Pharmacology and Experimental Therapeutics. 288: 759-65. PMID 9918586  0.279
1992 Skilling SR, Mullett MA, Beitz AJ, Larson AA. Fluorogold administration via microdialysis labels neurons terminating within the dialysis region. Journal of Neuroscience Methods. 41: 85-90. PMID 1349661 DOI: 10.1016/0165-0270(92)90126-X  0.279
1999 Li J, Simone DA, Larson AA. Windup leads to characteristics of central sensitization. Pain. 79: 75-82. PMID 9928779 DOI: 10.1016/S0304-3959(98)00154-7  0.278
1994 Mousseau DD, Sun X, Larson AA. An antinociceptive effect of capsaicin in the adult mouse mediated by the NH2-terminus of substance P. The Journal of Pharmacology and Experimental Therapeutics. 268: 785-90. PMID 7509392  0.277
1997 Larson AA, Kitto KF. Mutual antagonism between nerve growth factor and substance P N-terminal activity on nociceptive activity in mice. The Journal of Pharmacology and Experimental Therapeutics. 282: 1345-50. PMID 9316845  0.276
2017 Kissel CL, Kovács KJ, Larson AA. Evidence for the modulation of nociception in mice by central mast cells. European Journal of Pain (London, England). PMID 28722336 DOI: 10.1002/ejp.1086  0.267
1984 Larson AA, Wilcox GL. Synergistic behavioral effects of serotonin and tryptamine injected intrathecally in mice. Neuropharmacology. 23: 1415-8. PMID 6335574 DOI: 10.1016/0028-3908(84)90082-0  0.266
1997 Larson AA, Kitto KF. Manipulations of zinc in the spinal cord, by intrathecal injection of zinc chloride, disodium-calcium-EDTA, or dipicolinic acid, alter nociceptive activity in mice. The Journal of Pharmacology and Experimental Therapeutics. 282: 1319-25. PMID 9316841  0.265
2011 Larson AA, Thomas MJ, McElhose A, Kovács KJ. Spontaneous locomotor activity correlates with the degranulation of mast cells in the meninges rather than in the thalamus: disruptive effect of cocaine. Brain Research. 1395: 30-7. PMID 21561602 DOI: 10.1016/j.brainres.2011.04.033  0.254
1995 Larson AA, Kitto KF. Sensitization to the behavioral effect of kainic acid in the mouse is mediated by nitric oxide. The Journal of Pharmacology and Experimental Therapeutics. 275: 544-50. PMID 7473137  0.249
2014 Abdelhamid RE, Kovács KJ, Nunez MG, Larson AA. After a cold conditioning swim, UCP2-deficient mice are more able to defend against the cold than wild type mice. Physiology & Behavior. 135: 168-73. PMID 24952267 DOI: 10.1016/j.physbeh.2014.06.014  0.248
2006 Kovács KJ, Larson AA. Mast cells accumulate in the anogenital region of somatosensory thalamic nuclei during estrus in female mice. Brain Research. 1114: 85-97. PMID 16949055 DOI: 10.1016/j.brainres.2006.07.100  0.248
2014 Larson AA, Pardo JV, Pasley JD. Review of overlap between thermoregulation and pain modulation in fibromyalgia. The Clinical Journal of Pain. 30: 544-55. PMID 23887348 DOI: 10.1097/Ajp.0B013E3182A0E383  0.246
1980 Proudfit HK, Larson AA, Anderson EG. The role of GABA and serotonin in the mediation of raphe-evoked spinal cord dorsal root potentials. Brain Research. 195: 149-65. PMID 6249439 DOI: 10.1016/0006-8993(80)90873-2  0.232
1991 Baker AJ, Zornow MH, Grafe MR, Scheller MS, Skilling SR, Smullin DH, Larson AA. Hypothermia prevents ischemia-induced increases in hippocampal glycine concentrations in rabbits. Stroke; a Journal of Cerebral Circulation. 22: 666-73. PMID 2028499  0.229
2009 Russell IJ, Larson AA. Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis. Rheumatic Diseases Clinics of North America. 35: 421-35. PMID 19647152 DOI: 10.1016/j.rdc.2009.06.005  0.228
1995 Larson AA, Yukhananov RY, Kreeger JS. Enhanced N-methyl-D-aspartate (NMDA)-induced activity following morphine: sensitivity to sigma and PCP ligands. Nida Research Monograph. 147: 146-60. PMID 8742784  0.226
2001 Larson AA, Kovács KJ. Nociceptive aspects of fibromyalgia. Current Pain and Headache Reports. 5: 338-46. PMID 11403737 DOI: 10.1007/S11916-001-0023-0  0.224
2019 Pardo JV, Larson RC, Spencer RJ, Lee JT, Pasley JD, Torkelson CJ, Larson AA. Exposure to Cold Unmasks Potential Biomarkers of Fibromyalgia Syndrome Reflecting Insufficient Sympathetic Responses to Stress. The Clinical Journal of Pain. PMID 30768436 DOI: 10.1097/Ajp.0000000000000695  0.22
2008 Larson AA. Immune and Glial Regulation of Pain. Edited by Joyce A. DeLeo, PhD; Linda S. Sorkin, PhD; Linda R. Watkins, PhD Journal of Musculoskeletal Pain. 16: 358-359. DOI: 10.1080/10582450802479750  0.215
1979 Larson AA, Anderson EG. Changes in primary afferent depolarization after administration of gamma-acetylenic gamma aminobutyric acid (GAG), a gamma-aminobutyric acid (GABA) transaminase inhibitor. The Journal of Pharmacology and Experimental Therapeutics. 211: 326-30. PMID 501564  0.211
1990 Igwe OJ, Sun X, Larson AA. Role of substance P amino terminal metabolites in substance P-induced desensitization in mice. Neuroscience. 36: 535-42. PMID 1699171  0.209
2007 Taiwo OB, Russell IJ, Mignot E, Lin L, Michalek JE, Haynes W, Xiao Y, Zeitzer JM, Larson AA. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome. Sleep Medicine. 8: 260-5. PMID 17369087 DOI: 10.1016/J.Sleep.2006.08.015  0.203
1992 Parsons AM, Seybold VS, Chandan R, Vogt J, Larson AA, Murray CR, Soldani G, Brown DR. Neurokinin receptors and mucosal ion transport in porcine jejunum. The Journal of Pharmacology and Experimental Therapeutics. 261: 1213-21. PMID 1376358  0.2
1990 Krumins SA, Kim DC, Larson AA. Substance P modulation of [3H]DAGO binding in the brain of Swiss-Webster and CXBK (mu opioid receptor deficient) mice. Progress in Clinical and Biological Research. 328: 149-52. PMID 1689493  0.195
1984 Redig PT, Larson AA, Duke GE. Response of great horned owls given the optical isomers of ketamine. American Journal of Veterinary Research. 45: 125-7. PMID 6703445  0.16
1987 Magnusson KR, Clements JR, Larson AA, Madl JE, Beitz AJ. Localization of glutamate in trigeminothalamic projection neurons: a combined retrograde transport-immunohistochemical study. Somatosensory Research. 4: 177-90. PMID 2882592  0.157
1990 Krumins SA, Kim DC, Igwe OJ, Larson AA. Guanine nucleotide inhibition of DAMGO binding in the mouse brain, as modified by substance P and its fragments New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 163-165.  0.151
1983 Bird JE, Miller KW, Larson AA, Duke GE. Pharmacokinetics of gentamicin in birds of prey. American Journal of Veterinary Research. 44: 1245-7. PMID 6881663  0.119
1990 Smullin DH, Schamber CD, Skilling SR, Larson AA. A possible role for taurine in analgesia. Progress in Clinical and Biological Research. 351: 129-32. PMID 1700440  0.102
1999 Giovengo SL, Russell IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. The Journal of Rheumatology. 26: 1564-9. PMID 10405946  0.088
2015 Cort P, Larson A. The non-shock of PIAAC – Tracing the discursive effects of PIAAC in Denmark European Educational Research Journal. 14: 531-548. DOI: 10.1177/1474904115611677  0.07
2015 Zhao H, Ghirlando R, Alfonso C, Arisaka F, Attali I, Bain DL, Bakhtina MM, Becker DF, Bedwell GJ, Bekdemir A, Besong TM, Birck C, Brautigam CA, Brennerman W, Byron O, ... ... Larson A, et al. A multilaboratory comparison of calibration accuracy and the performance of external references in analytical ultracentrifugation. Plos One. 10: e0126420. PMID 25997164 DOI: 10.1371/Journal.Pone.0126420  0.063
1997 Larson AA, Kern S, Curtiss S, Gordon R, Cavenee WK, Hampton GM. High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Research. 57: 4082-90. PMID 9307297  0.062
2014 Kern E, Lin D, Larson A, Yang GY, Taft T, Zalewski A, Gonsalves N, Hirano I. Prospective assessment of the diagnostic utility of esophageal brushings in adults with eosinophilic esophagitis. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. PMID 25515533 DOI: 10.1111/Dote.12304  0.056
2017 Pardo JV, Lee JT, Larson RC, Thuras P, Larson AA. Automated quantitation of cold-inducible human brown adipose tissue with FDG PET/CT with application to fibromyalgia. American Journal of Nuclear Medicine and Molecular Imaging. 7: 24-32. PMID 28123865  0.055
2015 Larson A. Underground piping: Out of sight, out of mind, until it leaks Power. 159: 1-16.  0.041
1996 Larson AA, Kern S, Sommers RL, Yokota J, Cavenee WK, Hampton GM. Analysis of replication error (RER+) phenotypes in cervical carcinoma. Cancer Research. 56: 1426-31. PMID 8640835  0.039
1997 Larson AA, Liao SY, Stanbridge EJ, Cavenee WK, Hampton GM. Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Research. 57: 4171-6. PMID 9331069 DOI: 10.1097/00128360-199810000-00011  0.038
2014 Hedberg HM, Nkambule S, Larson A. Landau-Zener studies of mutual neutralization in collisions of H+ +H- and Be+ +H- Journal of Physics B: Atomic, Molecular and Optical Physics. 47. DOI: 10.1088/0953-4075/47/22/225206  0.036
1996 Hampton GM, Larson AA, Baergen RN, Sommers RL, Kern S, Cavenee WK. Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 93: 6704-9. PMID 8692882  0.034
2015 Cohen JM, Cheng CE, DeSouza A, Nandi TR, Buzney EA, Larson A, Lee WY, Mostaghimi A. Hypersensitivity reaction as a harbinger of acute myeloid leukemia: a case report and review of the literature. Annals of Dermatology. 27: 190-3. PMID 25834359 DOI: 10.5021/ad.2015.27.2.190  0.031
2015 Cronkleton P, Larson A. Formalization and Collective Appropriation of Space on Forest Frontiers: Comparing Communal and Individual Property Systems in the Peruvian and Ecuadoran Amazon Society and Natural Resources. 28: 496-512. DOI: 10.1080/08941920.2015.1014609  0.03
2006 Eliason MJ, Larson AA, Florell SR, Zone JJ, Cannon-Albright LA, Samlowski WE, Leachman SA. Population-based prevalence of CDKN2A mutations in Utah melanoma families. The Journal of Investigative Dermatology. 126: 660-6. PMID 16397522 DOI: 10.1038/Sj.Jid.5700094  0.028
2015 Talarico S, Safaeian M, Gonzalez P, Hildesheim A, Herrero R, Porras C, Cortes B, Larson A, Fang FC, Salama NR. Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage. Helicobacter. PMID 26667241 DOI: 10.1111/Hel.12289  0.028
2015 Overton TW, Larson A, Reitenbach G. Power digest: South Africa to develop continent's first CSP project Power. 159.  0.027
2007 Larson AA, Leachman SA, Eliason MJ, Cannon-Albright LA. Population-based assessment of non-melanoma cancer risk in relatives of cutaneous melanoma probands. The Journal of Investigative Dermatology. 127: 183-8. PMID 16902418 DOI: 10.1038/sj.jid.5700507  0.027
2015 Gattis MN, Larson A. Perceived Racial, Sexual Identity, and Homeless Status-Related Discrimination Among Black Adolescents and Young Adults Experiencing Homelessness: Relations With Depressive Symptoms and Suicidality. The American Journal of Orthopsychiatry. PMID 26460699 DOI: 10.1037/Ort0000096  0.025
2015 Larson A. Palo Verde nuclear station sets U.S. production record Power. 159.  0.023
2015 Kashireddy P, Larson A, Minturn L, Ernst L. Case Report of Autopsy and Placental Examination After Radiofrequency Ablation of an Acardiac Twin. Laboratory Medicine. 46: 248-53. PMID 26199267 DOI: 10.1309/LM4B4DU7UIMKLNAI  0.022
2015 Shah S, Larson A, Datta Y. Calciphylaxis in catastrophic antiphospholipid antibody syndrome. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 26: 467-8. PMID 25688465 DOI: 10.1097/MBC.0000000000000253  0.021
2015 Larson A. Ignalina: Decommissioning Chernobyl's big sister Power. 159.  0.021
2009 Larson AA, Britt MA, Kurby CA. Improving Students' Evaluation of Informal Arguments. Journal of Experimental Education. 77: 339. PMID 20174611 DOI: 10.3200/Jexe.77.4.339-366  0.02
2015 Larson A, Nokoff NJ, Meeks NJL. Genetic causes of pituitary hormone deficiencies Discovery Medicine. 19: 175-183.  0.02
2014 Spencer JH, Larson AA, Drake R, Iaizzo PA. A detailed assessment of the human coronary venous system using contrast computed tomography of perfusion-fixed specimens. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 11: 282-8. PMID 24144884 DOI: 10.1016/J.Hrthm.2013.10.038  0.018
2007 Larson AA, Goldman MP. Recalcitrant rosacea successfully treated with multiplexed pulsed dye laser. Journal of Drugs in Dermatology : Jdd. 6: 843-5. PMID 17763618  0.016
2015 Overton TW, Larson A, Reitenbach G. Power digest: Morocco adds solar thermal capacity Power. 159.  0.015
2015 Larson A, Overton TW. Proposed ozone rule may be the most costly regulation ever Power. 159.  0.015
2005 Larson AA, Dinulos JG. Cutaneous bacterial infections in the newborn. Current Opinion in Pediatrics. 17: 481-5. PMID 16012260 DOI: 10.1097/01.mop.0000171321.68806.bd  0.013
2015 Larson A. Cambodia's largest hydropower plant begins operation Power. 159.  0.013
2015 Larson A. Top plants: IPP3, Amman, Jordan owner/operator: Amman Asia Electric Power Co Power. 159.  0.01
2015 Rasmussen P, Larson A, Rönnberg L, Tsatsaroni A. Policies of ‘modernisation’ in European education: Enactments and consequences European Educational Research Journal. 14: 479-486. DOI: 10.1177/1474904115610783  0.01
2015 Wang R, Pekarek S, Bash ML, Larson A, Maaren RV. Incorporating Dynamics in a Mesh-Based Magnetic Equivalent Circuit Model of Synchronous Machines Ieee Transactions On Energy Conversion. DOI: 10.1109/TEC.2015.2403773  0.01
2015 Wang R, Pekarek S, Oregan P, Larson A, Van Maaren R. Incorporating Skew in a Magnetic Equivalent Circuit Model of Synchronous Machines Ieee Transactions On Energy Conversion. 30: 816-818. DOI: 10.1109/TEC.2014.2373034  0.01
2015 Ríos-Salas V, Larson A. Perceived discrimination, socioeconomic status, and mental health among Latino adolescents in US immigrant families Children and Youth Services Review. 56: 116-125. DOI: 10.1016/j.childyouth.2015.07.011  0.01
2015 Overton TW, Larson A, Reitenbach G. Power digest: Construction begins on UK biomass plant Power. 159.  0.01
2015 Overton TW, Larson A, Reitenbach G. Power digest: Saudi Arabia plans first CSP-combined cycle plant Power. 159.  0.01
2015 Larson A. Egypt moves to boost gas and wind generation Power. 159: 1-9.  0.01
2015 Winders W, Cornel C, Larson A, Cunha SA, Moses S, Rowe DC, Wilkinson L. Cyber war is not gender war - Experiences of creating a productive heterogeneous environment in cyber security research Asee Annual Conference and Exposition, Conference Proceedings. 2015.  0.01
2015 Larson A. Innovative wind turbine blade inspection and maintenance tools Power. 159: 1-13.  0.01
2015 Overton TW, Larson A, Reitenbach G. Power digest: Novel wind power system to be tested in florida. SheerWind Power. 159.  0.01
2015 Larson A. Riding off into the sunset: Nuclear decontamination and decommissioning update Power. 159.  0.01
2007 Leachman SA, Jackson R, Eliason MJ, Larson AA, Bolognia JL. Management of melanoma during pregnancy. Dermatology Nursing / Dermatology Nurses' Association. 19: 145-52, 161. PMID 17526302  0.01
Hide low-probability matches.